In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
410 News Items found
Cyclotron engineer and nuclear pharmacist
In the Lab
New Technology May Improve Treatment of Deadly Lung and Prostate Cancers

Learn how a new technology could improve detection and treatment of certain aggressive lung and prostate cancers.
A researcher working in an MSK lab
MSK Research Highlights, July 15, 2025

New MSK research investigates whether introducing new mutations could make immunotherapy more effective against some cancers; shows that people in their 90s who underwent lung cancer surgery had positive outcomes; shares lessons on the responsible governance of artificial intelligence in oncology; studies AI-assisted biomarker assessment in lung cancer; and demonstrates a cancer-trained large language model has strong predictive value.
MSK patient Joanne Ferrari-Mautino seen outdoors with her son and boyfriend.
How ROS1-Targeted Therapy Is Helping People With Advanced Lung Cancer Live Better, Longer

Learn how MSK is helping people with lung cancer driven by ROS1 fusions, thanks to continual improvements in specific targeted therapies.
Physician-scientist Piro Lito
In the Lab
Why KRAS Inhibitors for Lung Cancer Stop Working (and What Can Be Done about It)

Recently developed targeted drugs used to treat lung cancer are only partially effective. Scientists now know why.
Fiona and Stanley Druckenmiller
Donors on a Mission to Fast-Track Cancer Therapies at MSK

Meet Fiona and Stanley Druckenmiller, whose latest venture supports promising new avenues of research for experts at Memorial Sloan Kettering Cancer Center.
An immunofluorescence image of an aged mouse liver
Top Cancer Research Advances at MSK in 2024

MSK researchers continued to make strides against cancer in 2024. Learn about some of their top discoveries.
Charles Rudin with lab member
ASCO 2020: Advances in the Treatment of Small-Cell Lung Cancer

During the upcoming ASCO Virtual Scientific Program, MSK Chief of Thoracic Oncology Service Charles M. Rudin, MD, PhD, will present a study that found pembrolizumab addition to first-line chemotherapy significantly improved progression-free survival for patients with small cell lung cancer (SCLC).
MSK's Justin Jee, MD, PhD, and Ed Reznik, PhD, are seen smiling.
New Insights Into How Obesity Influences Cancer Driver Mutations

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, including lung and endometrial cancers.
MSK patient Anthony Valente and Dr. Alexander Drilon
FDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions

Zidesamtinib, a new drug that treats non-small cell lung cancer carrying a mutation called a ROS1 fusion, has been approved by the FDA.
Microscope image showing lung metastasis
TGF-Beta and RAS Signaling Are Both Required for Lung Cancer Metastasis, Study Finds

MSK researchers have identified two signaling pathways that work together to spur the spread of lung cancer. Taking away one of those signals could help slow or stop metastasis, findings in animal models suggest.